Our Experts

At NDA we’re a team of experts – experts in the regulated disciplines, and experts in drug development.

Some of us have attained our experience from working inside regulatory authorities, carefully assessing the benefits and risks of new treatments. Some of us have worked for years in the biotech and pharmaceutical industry, patiently developing life changing products for patients suffering from debilitating and sometimes deadly diseases and conditions.

Whatever our background, we share a passion for the art and science of drug development and for making a difference to the clients and the patients we ultimately serve.

Get to know the people behind the passion – read more about our incredible team below.


Amy Blawas

Principal Consultant
Expert in advanced therapies and regulatory strategy

Dr Andrea Pless

Principal Consultant
Expert in CMC, drug development and product lifecycle management

Dr Paula Salmikangas

Advisory Board Director
Expert in biological medicinal products

Dr Roz Cox

Principal Consultant
Expert in European and Global Regulatory Affairs

Dr Steffen Thirstrup

Advisory Board Director
Expert in EU regulatory system and clinical/regulatory strategies

Dr Thomas Lönngren

Strategic Advisor
Expert in the EU regulatory system and global regulatory strategies

Dr Tina Amini

Medical Device Division Director
Expert in medical devices regulations

Kimberley Forbes-McKean

VP Regulatory & Strategy US
Expert in global clinical and regulatory strategies

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.